Enhancement of poly‐adenosine diphosphate‐ribosylation in human hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Gastroenterology and Hepatology

• Publication date

  2000-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1440-1746.2000.02193.xPMID 10847440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of hepatic poly(ADP-ribose) polymerase by peroxisome proliferators, non-genotoxic hepatocarcinogens.

  1998cited by this paper
• Isolation and Characterization of the cDNA Encoding Bovine Poly(ADP-ribose) Glycohydrolase*

  1997cited by this paper
• Serum NAD glycohydrolase activities in normal subjects and in patients with chronic liver diseases.

  1997cited by this paper
• Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease.

  1997cited by this paper
• Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death.

  1997cited by this paper
• Long‐term alcohol intake enhances ADP‐ribosylation of the multifunctional enzyme, phosphoglucomutase, in rat liver

  1996cited by this paper
• Immunohistochemical localization of NAD glycohydrolase in human and rabbit tissues

  1995cited by this paper
• Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.

  1995cited by this paper
• Identification and purification of a bovine liver mitochondrial NAD+‐glycohydrolase

  1995cited by this paper
• Stimulation of mono‐ADP ribosylation in rat liver plasma membranes after long‐term alcohol intake

  1993cited by this paper
• Ursodeoxicholate and protein kinases modulate the chenodeoxicholate-induced intracellular signaling in isolated rat hepatocytes

  1993cited by this paper
• Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma

  1992cited by this paper
• Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase.

  1992cited by this paper
• Hepatocellular carcinoma: Recent progress

  1992cited by this paper
• Relation between carcinogenesis, chromatin structure and poly(ADP-ribosylation) (review).

  1991cited by this paper
• Regulation of poly(ADP-ribose) polymerase mRNA levels during compensatory and mitogen-induced growth of rat liver.

  1990cited by this paper
• Possible involvement of poly ADP-ribosylation in phenobarbital promotion of rat hepatocarcinogenesis.

  1990cited by this paper
• Loss of the MYC gene amplified in human HL-60 cells after treatment with inhibitors of poly(ADP-ribose) polymerase or with dimethyl sulfoxide.

  1989cited by this paper
• ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins.

  1988cited by this paper
• ADP-ribosylation.

  1985cited by this paper
• Islet-activating protein, pertussis toxin: a probe for functions of the inhibitory guanine nucleotide regulatory component of adenylate cyclase

  1984cited by this paper
• Poly (ADP-ribosylation) in N, N-diethylnitrosamine-treated mice.

  1982cited by this paper
• DNA strand breaks and ADP-ribosyl transferase activation during cell differentiation

  1982cited by this paper
• Studies of nuclear ADP-ribosylation.

  1980cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies

  1954cited by this paper

• Expression of LC3A, LC3B and p62/SQSTM1 autophagy proteins in hepatocellular carcinoma (HCC) tissues and the predicted microRNAs involved in the autophagy-related pathway

  2024cites this paper
• Hepatitis B virus infection disrupts homologous recombination in hepatocellular carcinoma by stabilizing resection inhibitor ADRM1

  2023cites this paper
• Early in vitro evidence indicates that deacetylated sialic acids modulate multi-drug resistance in colon and lung cancers via breast cancer resistance protein

  2023cites this paper
• Fluorescence-Based Analyses of Poly(ADP-Ribose) Length by Gel Electrophoresis, High-Performance Liquid Chromatography, and Capillary Electrophoresis.

  2023cites this paper
• Poly(ADP-Ribose) Polymerase Inhibition as a Promising Approach for Hepatocellular Carcinoma Therapy

  2022cites this paper
• Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing

  2022cites this paper
• Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer

  2021cites this paper
• Inhibiting Src-mediated PARP1 tyrosine phosphorylation confers synthetic lethality to PARP1 inhibition in HCC.

  2021cites this paper
• Therapeutic Potential of PARP Inhibitors in the Treatment of Gastrointestinal Cancers

  2021cites this paper
• Computational Compensatory Mutation Discovery Approach: Predicting a PARP1 Variant Rescue Mutation

  2021cites this paper
• Pleiotropic role of PARP1: an overview

  2021cites this paper
• Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma

  2020cites this paper
• microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis

  2020cites this paper
• Proteomics Profiling of KAIMRC1 in Comparison to MDA-MB231 and MCF-7

  2020cites this paper
• A functional polymorphism in the poly(ADP-ribose) polymerase-1 gene is associated with platinum-based chemotherapeutic response and prognosis in epithelial ovarian cancer patients.

  2020cites this paper
• Identification and quantification of DNA repair protein poly(ADP ribose) polymerase 1 (PARP1) in human tissues and cultured cells by liquid chromatography/isotope-dilution tandem mass spectrometry.

  2019cites this paper
• PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies.

  2019cites this paper
• Precision medicine in gastric cancer

  2019cites this paper
• Dysregulated Epigenetic Modifications in the Pathogenesis of NAFLD-HCC.

  2018cites this paper
• PARP-1 Overexpression as an Independent Prognostic Factor in Adult Non-M3 Acute Myeloid Leukemia

  2018cites this paper
• A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours

  2018cites this paper
• The Association between PARP1 and LIG3 Expression Levels and Chromosomal Translocations in Acute Myeloid Leukemia Patients

  2018cites this paper
• Title Elevated Expression of Poly ( ADP-Ribose ) Polymerase-1 is Associatedwith Liver Metastasis in Colorectal Cancer

  2018cites this paper
• Functional, Metabolic, and Dynamic Mitochondrial Changes in the Rat Cirrhosis-Hepatocellular Carcinoma Model and the Protective Effect of IFC-305

  2017cites this paper
• Poly-(ADP-Ribose) Polymerase-1 Promotes Prothrombin Gene Transcription and Produces Des-Gamma-Carboxy Prothrombin in Hepatocellular Carcinoma

  2017cites this paper
• PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies.

  2017cites this paper
• Expression and Single Nucleotide Polymorphism of Poly (ADPRibose) Polymerase-1 in Gastrointestinal Tumours: Clinical Involvement.

  2017cites this paper
• Human colon cancer HT-29 cell death responses to doxorubicin and Morus Alba leaves flavonoid extract.

  2016cites this paper
• Identification of benzothiophene amides as potent inhibitors of human nicotinamide phosphoribosyltransferase.

  2016cites this paper
• Combination PARP and HDAC inhibition as a therapeutic strategy targeting liver cancer stem cells?

  2016cites this paper
• Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma

  2016cites this paper
• Trial watch – inhibiting PARP enzymes for anticancer therapy

  2016cites this paper
• Inhibition of poly(ADP-ribose) polymerase 1 protects against acute myeloid leukemia by suppressing the myeloproliferative leukemia virus oncogene

  2015cites this paper
• Effectiveness and safety of poly (ADP-ribose) polymerase inhibitors in cancer therapy: A systematic review and meta-analysis

  2015cites this paper
• Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma

  2015influential citation
• PARP1 expression in mantle cell lymphoma: the utility of PARP1 immunohistochemistry and its relationship with markers of DNA damage

  2015cites this paper
• Inhibition of DNA Repair as a Therapeutic Target

  2014cites this paper
• Update on hepatocellular carcinoma breakthroughs: poly(ADP-ribose) polymerase inhibitors as a promising therapeutic strategy.

  2014cites this paper
• Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases.

  2014cites this paper
• Parp‐1 genetic ablation in Ela–myc mice unveils novel roles for Parp‐1 in pancreatic cancer

  2014cites this paper
• Poly(ADP-ribosylation) and neoplastic transformation: effect of PARP inhibitors.

  2013cites this paper
• PARP and PARP Inhibitor Therapeutics

  2013cites this paper
• Nicotinamide phosphoribosyltransferase inhibitors, design, preparation, and structure-activity relationship.

  2013cites this paper
• [Studies on the mode of action of bacterial AB5 toxins].

  2013cites this paper
• The Role of PARP Activation in Prostate Cancer

  2013cites this paper
• Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models.

  2013cites this paper
• Translocation t(11;14) (q13;q32) and genomic imbalances in multi-ethnic multiple myeloma patients: a Malaysian study

  2012cites this paper
• Design, synthesis and X-ray crystallographic study of NAmPRTase inhibitors as anti-cancer agents.

  2011cites this paper
• Changes in expression of some apoptotic markers in different types of human endometrium.

  2011cites this paper
• PARP-1 activity in normal and cancerous human endometrium and its relationship with quantity of abasic sites (AP).

  2011cites this paper
• PARP-1 activity in normal and cancerous human endometrium and its relationship with quantity of abasic sites (AP) AktywnoÊç PARP-1 w prawidΠowym i nowotworowym endometrium w relacji do liczby miejsc apurynowych/ apirymidynowych

  2011cites this paper
• Nampt/PBEF/visfatin and cancer

  2010cites this paper
• Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types.

  2010cites this paper
• Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase

  2010influential citation
• NAD(P) biosynthesis enzymes as potential targets for selective drug design.

  2009cites this paper
• Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines

  2009influential citation
• [Analysis of gene expression in primary hepatocellular carcinoma using differentially displayed reverse transcriptase polymerase chain reaction].

  2009cites this paper
• 18O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma

  2008cites this paper
• he adjuvant effects of Antrodia Camphorata extracts combined ith anti-tumor agents on multidrug resistant uman hepatoma cells

  2008cites this paper
• Anticancer agent CHS-828 inhibits cellular synthesis of NAD.

  2008cites this paper
• Enzymology of mammalian NAD metabolism in health and disease.

  2008cites this paper
• Enzymology of NAD metabolism Enzymology of mammalian NAD metabolism in health and disease

  2008cites this paper
• PJ34, an inhibitor of PARP-1, suppresses cell growth and enhances the suppressive effects of cisplatin in liver cancer cells.

  2008cites this paper
• Potentiation of Temozolomide Cytotoxicity by Poly(ADP)Ribose Polymerase Inhibitor ABT-888 Requires a Conversion of Single-Stranded DNA Damages to Double-Stranded DNA Breaks

  2008cites this paper
• The adjuvant effects of Antrodia Camphorata extracts combined with anti-tumor agents on multidrug resistant human hepatoma cells.

  2008cites this paper
• Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity.

  2008cites this paper
• Poly(ADP-ribose) polymerase-1 regulates vimentin expression in lung cancer cells.

  2007cites this paper
• Comparative proteomic analysis on human L-02 liver cells treated with varying concentrations of trichloroethylene

  2007cites this paper
• Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissues.

  2007cites this paper
• Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.

  2007cites this paper
• Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial

  2007cites this paper
• Helicobacter pylori induces mono-(adenosine 5'-diphosphate)-ribosylation in human gastric adenocarcinoma.

  2006cites this paper
• Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region.

  2005cites this paper
• New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response

  2005cites this paper
• Expression of poly(ADP-ribose) polymerase in human hepatocellular carcinoma and analysis of biopsy specimens obtained under sonographic guidance.

  2004cites this paper
• Novel Mechanism for Induction of Tumor Cell Apoptosis Nicotinamide Phosphoribosyltransferase , Represents a FK 866 , a Highly Specific Noncompetitive Inhibitor of Updated

  2003cites this paper
• FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.

  2003cites this paper
• Interactive effects of poly(ADP-ribose) polymerase -1 and DNA dependent protein kinase in the cellular responses to DNA damage

  2003cites this paper